|
Date: Feb 8, 2012
| Source: Urology Times eNews
Brachytherapy alone, or in combination with external beam radiation therapy (EBRT), significantly reduces mortality rates in patients with high-risk prostate cancer, report the authors of a study from Thomas Jefferson University, Philadelphia.
Date: Feb 8, 2012
| Source: Urology Times eNews
The 5-alpha-reductase inhibitor dutasteride (Avodart) appears to delay disease progression and the initiation of active treatment in men with low-risk, localized prostate cancer, results of a 3-year international clinical trial indicate.
Date: Feb 2, 2012
By:
From staff reports
| Source: Drug Topics Hospital Pharmacists' Report
|
Dutasteride (Avodart, GlaxoSmithKline) delays the progression of prostate cancer in men with low-risk prostate cancer, according to a new study.
Date: Feb 1, 2012
| Source: Urology Times eNews
A scale used to measure bone metastases has been found useful in determining whether some prostate cancer patients are responding to chemotherapy, report researchers from Memorial Sloan-Kettering Cancer Center, New York.
Date: Feb 1, 2012
| Source: Urology Times eNews
New Jersey Governor Chris Christie has signed legislation opposing an October 2011 U.S. Preventive Services Task Force (USPSTF) draft recommendation that healthy men should no longer receive PSA tests as part of routine cancer screening.
Date: Feb 1, 2012
| Source: Urology Times eNews
Prostate cancer patients tend to opt for a major cancer center if they have severe disease, but stay closer to home for less complicated cases, even when offered a model of care that taps numerous experts, according to a study by researchers from Duke Cancer Institute, Durham, NC.
Date: Jan 25, 2012
| Source: Urology Times eNews
The risks of incontinence and sexual dysfunction are high after both robot-assisted laparoscopic radical prostatectomy and open radical prostatectomy among Medicare-age men, results of a recent multicenter study show.
Date: Jan 25, 2012
| Source: Urology Times eNews
Veterans Affairs hospitals screen elderly men with limited life expectancies for prostate cancer at surprisingly high rates, even though guidelines recommend against such screening, according to a recent study.
Date: Jan 25, 2012
| Source: Urology Times eNews
Obesity appears to be associated with higher rates of prostate cancer screening across all races and ethnicities, recent study findings indicate.
|
| 
Practice Tools
